ÂÜÀòÂÒÂ×

Tove Holm-Larsen has a diverse work experience in the fields of healthcare, pharmaceuticals, and data analysis. Tove is currently the Chief Executive Officer at Silvi.ai, a software company that supports systematic literature reviews and meta-analysis. Prior to this, Tove served as a guest professor at the University of Ghent, where they conducted research on integrating digital health into urological clinical trials. Tove was also a blogger on pharma trends and challenges for Dagens Pharma's Discussion Panel and Dagbladet Børsen, the prominent financial newspaper in Denmark. Tove founded DataFair, a company focused on using Danish health data to improve medical treatment and lower drug development costs. Tove also has experience as a CEO at Pharma Evidence, providing strategic advice in health economics and outcome research for pharmaceutical and medical device companies. Tove served as a board member at LifeGuard Health and as part of various interest and execution groups related to evidence-based medicine, biotech execution, and advisory board memberships.

Tove Holm-Larsen pursued their education at various institutions. In 2004, they attended the University of Copenhagen, where they focused on the field of study in quality of life and health economics. Tove continued their academic journey at the University of York in 2008, where they engaged in Ph.D. courses in health economical modelling. That same year, they also participated in Ph.D. courses at Harvard T.H. Chan School of Public Health, specifically in patient-reported outcome. Furthermore, there is no information regarding their educational experience at Roskilde University.